Cargando…
Comparing Genetic Risk and Clinical Risk Classification in Luminal-like Breast Cancer Patients Using a 23-Gene Classifier
SIMPLE SUMMARY: Multi-gene expression assays have been advocated for treatment decision in breast cancer management. The most commonly used assays such as Oncotype DX, MammaPrint, which were developed from the Western population, were especially designed for the prognostication of early stage lumina...
Autores principales: | Huang, Chi-Cheng, Chen, Ting-Hao, Liu, Liang-Chih, Huang, Chiun-Sheng, Liang, Ji-An, Hsu, Yu-Chen, Hsieh, Chia-Ming, Huang, Sean-Lin, Shih, Kuan-Hui, Tseng, Ling-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776657/ https://www.ncbi.nlm.nih.gov/pubmed/36551748 http://dx.doi.org/10.3390/cancers14246263 |
Ejemplares similares
-
Prognostic Comparison between Oncotype DX(®) and a 23-Gene Classifier, RecurIndex(®), on the Taiwan Breast Cancer Population
por: Chang, Chuan-Hsun, et al.
Publicado: (2022) -
Luminal pressure gradient and risk of arteriovenous fistula nonmaturation
por: Kuo, Chi-Heng, et al.
Publicado: (2022) -
Correlation of ER, PR, and HER2 at the protein and mRNA levels in Asian patients with operable breast cancer
por: Chen, Chih-Jung, et al.
Publicado: (2022) -
A High Resolution Melting Analysis-Based Genotyping Toolkit for the Peach (Prunus persica) Chilling Requirement
por: Chou, Lin, et al.
Publicado: (2020) -
Collinear search impairment is luminance contrast invariant
por: Tseng, Chia-huei, et al.
Publicado: (2021)